We are live on ! Find out more
VLC

Van Leeuwen & Company Portfolio holdings

AUM $197M
1-Year Est. Return 44.16%
This Fund
S&P 500
This Quarter Est. Return
+10.45%
1 Year Est. Return
+44.16%
3 Year Est. Return
+75.42%
5 Year Est. Return
+199.79%
10 Year Est. Return
AUM
$159M
AUM Growth
+$10.4M
Cap. Flow
-$1.99M
Cap. Flow %
-1.25%
Top 10 Hldgs %
43.29%
Holding
83
New
11
Increased
18
Reduced
41
Closed
7

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.05M
2
NEE icon
NextEra Energy
NEE
+$1.42M
3
TMO icon
Thermo Fisher Scientific
TMO
+$1.13M
4
MSCI icon
MSCI
MSCI
+$997K
5
AON icon
Aon
AON
+$906K

Sector Composition

Rank Sector Weight
1 Technology 17.24%
2 Healthcare 13.36%
3 Consumer Discretionary 12.42%
4 Financials 9.9%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EFA icon
1
iShares MSCI EAFE ETF
EFA
$78B
$9.65M 6.06%
133,305
-6,034
-4% -$438K
AAPL icon
2
Apple
AAPL
$4.54T
$8.72M 5.47%
45,312
-917
-2% -$160K
SPY icon
3
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$8.4M 5.27%
18,919
+3,571
+23% +$1.5M
MSFT icon
4
Microsoft
MSFT
$3.45T
$7.49M 4.7%
22,153
-1,308
-6% -$410K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.36T
$7.24M 4.55%
60,089
-2,111
-3% -$244K
BRK.B icon
6
Berkshire Hathaway Class B
BRK.B
$1.1T
$5.79M 3.64%
16,940
-694
-4% -$227K
V icon
7
Visa
V
$684B
$5.76M 3.61%
24,184
+322
+1% +$73.7K
IWM icon
8
iShares Russell 2000 ETF
IWM
$79.8B
$5.43M 3.41%
28,939
-1,801
-6% -$321K
ROST icon
9
Ross Stores
ROST
$80.5B
$5.34M 3.35%
48,096
-1,200
-2% -$126K
BMY icon
10
Bristol-Myers Squibb
BMY
$133B
$5.15M 3.23%
80,000
-2,575
-3% -$173K
SPYV icon
11
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.1B
$4.97M 3.12%
114,833
-13,627
-11% -$563K
XLE icon
12
State Street Energy Select Sector SPDR ETF
XLE
$39.6B
$4.49M 2.82%
110,486
+42,180
+62% +$1.72M
AVGO icon
13
Broadcom
AVGO
$1.85T
$3.99M 2.5%
45,470
-1,770
-4% -$126K
TJX icon
14
TJX Companies
TJX
$174B
$3.94M 2.48%
46,825
-2,526
-5% -$199K
LLY icon
15
Eli Lilly
LLY
$1.02T
$3.67M 2.3%
7,950
-1,252
-14% -$525K
VRTX icon
16
Vertex Pharmaceuticals
VRTX
$121B
$3.44M 2.16%
9,907
+216
+2% +$72.8K
T icon
17
AT&T
T
$159B
$3.44M 2.16%
213,505
-3,593
-2% -$61.2K
VWO icon
18
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$3.36M 2.11%
81,904
-3,904
-5% -$157K
AMZN icon
19
Amazon
AMZN
$2.92T
$2.85M 1.79%
21,873
+4,167
+24% +$476K
BA icon
20
Boeing
BA
$171B
$2.82M 1.77%
13,365
+3,208
+32% +$666K
ON icon
21
ON Semiconductor
ON
$31.8B
$2.58M 1.62%
26,674
+1,113
+4% +$92.1K
DHI icon
22
D.R. Horton
DHI
$40B
$2.31M 1.45%
19,208
-563
-3% -$61.6K
UL icon
23
Unilever
UL
$137B
$2.3M 1.45%
39,170
-579
-1% -$34.4K
JNJ icon
24
Johnson & Johnson
JNJ
$618B
$2.26M 1.42%
13,819
+152
+1% +$24.5K
SNA icon
25
Snap-on
SNA
$21.2B
$2.19M 1.38%
7,645
-398
-5% -$103K

Similar funds

Van Leeuwen & Company's Q2 2023 Portfolio in Review

As of Q2 2023, Van Leeuwen & Company held 83 positions worth $159M, up 7% from $149M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Van Leeuwen & Company's Q2 2023 filing shows 11 new, 18 increased, 41 reduced and 7 closed positions. Its largest new stake was DexCom: 15,579 shares worth $1.98M. The largest sale was AbbVie, an estimated $3.05M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Van Leeuwen & Company's largest Q2 2023 buy was DexCom: 15,579 shares worth $1.98M.
  • Van Leeuwen & Company added most to State Street Energy Select Sector SPDR ETF in Q2 2023, an estimated $1.72M increase.
  • Van Leeuwen & Company's biggest Q2 2023 reduction was Thermo Fisher Scientific, cutting an estimated $1.13M.
  • Van Leeuwen & Company fully exited AbbVie in Q2 2023, selling an estimated $3.05M.
  • Van Leeuwen & Company's ten largest holdings make up 43% of its $159M portfolio in Q2 2023.
  • Van Leeuwen & Company opened 11 new positions and closed 7 in Q2 2023.
  • Van Leeuwen & Company's portfolio value rose 7% quarter-over-quarter to $159M.

Based on Van Leeuwen & Company's 13F filing for Q2 2023, filed 7 Aug 2023.